These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 2751197)
41. Repair of cytotoxic lesions introduced into DNA by methylating agents. Karran P; Hall J Ann Ist Super Sanita; 1989; 25(1):21-6. PubMed ID: 2665601 [TBL] [Abstract][Full Text] [Related]
42. Cellular resistance to chloroethylnitrosoureas, nitrogen mustard, and cis-diamminedichloroplatinum(II) in human glial-derived cell lines. Aida T; Bodell WJ Cancer Res; 1987 Mar; 47(5):1361-6. PubMed ID: 3469016 [TBL] [Abstract][Full Text] [Related]
43. Induction of c-fos, c-jun, junB and junD mRNA and AP-1 by alkylating mutagens in cells deficient and proficient for the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability. Dosch J; Kaina B Oncogene; 1996 Nov; 13(9):1927-35. PubMed ID: 8934539 [TBL] [Abstract][Full Text] [Related]
44. Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents. Kokkinakis DM; Ahmed MM; Delgado R; Fruitwala MM; Mohiuddin M; Albores-Saavedra J Cancer Res; 1997 Dec; 57(23):5360-8. PubMed ID: 9393761 [TBL] [Abstract][Full Text] [Related]
45. The relevance of DNA repair in the cytotoxic response of mammalian cells to alkylating agents. Citti L; Mariani L; Catapano CV; Malvaldi G Ann Ist Super Sanita; 1989; 25(1):5-9. PubMed ID: 2751197 [TBL] [Abstract][Full Text] [Related]
46. O6-alkylguanine-DNA alkyltransferase: role in carcinogenesis and chemotherapy. Margison GP; Santibáñez-Koref MF Bioessays; 2002 Mar; 24(3):255-66. PubMed ID: 11891762 [TBL] [Abstract][Full Text] [Related]
47. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. Kaina B; Christmann M; Naumann S; Roos WP DNA Repair (Amst); 2007 Aug; 6(8):1079-99. PubMed ID: 17485253 [TBL] [Abstract][Full Text] [Related]
48. Therapeutic impact of methoxyamine: blocking repair of abasic sites in the base excision repair pathway. Liu L; Gerson SL Curr Opin Investig Drugs; 2004 Jun; 5(6):623-7. PubMed ID: 15242251 [TBL] [Abstract][Full Text] [Related]
49. DNA adducts and the mechanism of carcinogenesis and cytotoxicity of methylating agents of environmental and clinical significance. Kyrtopoulos SA; Anderson LM; Chhabra SK; Souliotis VL; Pletsa V; Valavanis C; Georgiadis P Cancer Detect Prev; 1997; 21(5):391-405. PubMed ID: 9307842 [TBL] [Abstract][Full Text] [Related]
50. Cellular defence mechanisms against alkylating agents. Karran P; Lindahl T Cancer Surv; 1985; 4(3):583-99. PubMed ID: 2446750 [No Abstract] [Full Text] [Related]
51. N-nitroso alkylating agents: formation and persistence of alkyl derivatives in mammalian nucleic acids as contributing factors in carcinogenesis. Singer B J Natl Cancer Inst; 1979 Jun; 62(6):1329-39. PubMed ID: 374817 [No Abstract] [Full Text] [Related]
52. Alkylating agents relating to carcinogenesis in man. Montesano R; Hall J; Wild CP Prog Clin Biol Res; 1992; 374():175-96. PubMed ID: 1620703 [No Abstract] [Full Text] [Related]
54. Drug resistance and DNA repair. Fox M; Roberts JJ Cancer Metastasis Rev; 1987; 6(3):261-81. PubMed ID: 3319272 [TBL] [Abstract][Full Text] [Related]
55. The 1987 Walter Hubert lecture. Regulation and deficiencies in DNA repair. Lindahl T Br J Cancer; 1987 Aug; 56(2):91-5. PubMed ID: 3311110 [TBL] [Abstract][Full Text] [Related]